BioStock: PHI “It’s the right moment to capitalize on regenerative medicine momentum.”

May 23, 2024
Language flag

Medtech company Phase Holographic Imaging recently secured a loan facility of SEK 7 million. The company has decided to draw the first tranche from that loan — SEK 4.5 million. In a press release, CEO Patrik Eschricht stated that this provides an opportunity to act on the company’s current momentum. BioStock talked to Eschricht to learn more.

Read the full interview with Patrik Eschricht on biostock.se.

This strategic loan enables us to better lay the groundwork for entering the clinical market. We can leverage the current momentum and accelerate our development projects and product-to-market timeline.

Further reading

PHI published a detailed perspective discussing the versatility and potential the Company sees for Quantitative Phase Imaging (QPI) technology in Regenerative Medicine. PHI outlines how QPI will offer enhanced cell quality control in the cell manufacturing process, thereby addressing a central puzzle piece for making cell-based therapies safe, affordable, and accessible for all.

Read about PHI’s vision for QPI technology in Regenerative Medicine

Latest News

Interview-John-More-website

Interview with John Moore

Meet John Moore, the proposed new board member for PHI. John’s extensive experience and visionary mindset make him an invaluable addition to our team. Let’s dive into his journey and what made him interested in PHI.

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 19 August 2024

Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the “Company”), will hold an extraordinary general meeting on 19 August at 14:00 at the Company’s premises at Skiffervägen 48 in Lund.

Board member Leland Foster resigns due to personal reasons

PHI announces the resignation of esteemed board member Leland Foster. Mr. Foster has decided to resign from his position due to his age and his desire to retire from professional commitments. After this, the Board of Directors continues to have a quorum in accordance with the Articles of Association.
See All News